Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quinacrine in Androgen-Independent Metastatic Prostate Cancer
NCT00417274Phase 2Completed
- Sponsor
- Cleveland BioLabs, Inc.
- Start
- Dec 2006
- Primary completion
- May 2008
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of quinacrine in prostate cancer (PCa), sponsored by Cleveland BioLabs, Inc.. Started Dec 2006; status: completed.
02
Drugs
quinacrine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00417274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00417274.